BridgeMD
New treatment option for Gingival Recession, Localized
Official title Palatal Wound Healing After Free Gingival Graft Surgery
ClinicalTrials.gov ID: NCT07409571
What this study is testing
What is triamcinolone acetonide?
triamcinolone acetonide is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for gingival recession, localized.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This randomized controlled clinical trial aims to evaluate the effects of topical triamcinolone acetonide application on wound healing and patient-reported outcomes at the palatal donor site following free gingival graft (FGG) surgery. A total of 55 patients with mucogingival deficiencies requiring FGG will be randomly assigned to either a control group receiving a collagen membrane or a test group receiving topical triamcinolone acetonide at the donor site.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Adults aged 18 years and older
- Patients presenting with insufficient attached gingiva and/or gingival recession requiring free gingival graft surgery
- Systemically healthy individuals (ASA I)
- Full-mouth plaque score (FMPS) \< 15% and full-mouth bleeding score (FMBS) \< 15% at the time of surgery
- Ability and willingness to provide written informed consent and comply with study procedures
You likely can't join if
- Presence of systemic diseases that may affect wound healing (e.g., diabetes mellitus, immunological disorders)
- Use of systemic corticosteroids, immunosuppressive drugs, or anti-inflammatory medications within the last 3 months
- Current smokers or tobacco users
- Pregnancy or lactation
- History of periodontal surgery at the palatal donor site
- Presence of active infection, ulceration, or pathological lesions at the palatal donor area
See the full eligibility criteria
- Adults aged 18 years and older
- Patients presenting with insufficient attached gingiva and/or gingival recession requiring free gingival graft surgery
- Systemically healthy individuals (ASA I)
- Full-mouth plaque score (FMPS) \< 15% and full-mouth bleeding score (FMBS) \< 15% at the time of surgery
- Ability and willingness to provide written informed consent and comply with study procedures
- Presence of systemic diseases that may affect wound healing (e.g., diabetes mellitus, immunological disorders)
- Use of systemic corticosteroids, immunosuppressive drugs, or anti-inflammatory medications within the last 3 months
- Current smokers or tobacco users
- Pregnancy or lactation
- History of periodontal surgery at the palatal donor site
- Presence of active infection, ulceration, or pathological lesions at the palatal donor area
- Known allergy or hypersensitivity to corticosteroids, collagen materials, or study-related medications
The study team makes the final eligibility decision.
Where it's taking place
- Kahramanmaraş, Kahramanmaraş, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Kahramanmaraş, Kahramanmaraş, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.